Tuesday, June 13, 2023
9:30 AM - 10:10 AMWatch Panel Here
CAR-T cell therapy has been a game-changer for some patients with hematologic malignancies, yielding remarkable responses. Now, researchers are working to adapt and harness this technology not only to target solid tumors, but also to improve outcomes in liquid tumors. This panel will discuss the latest advances in this field — which strategies seem to hold promise, and where innovation can help move the needle for this important therapeutic modality.